Optain

Optain is a healthcare artificial intelligence company operating in the New York City AI scene [1]. The company works to make retinal screening simple, accessible, and standard in frontline care [2]. Diabetic retinopathy is a leading cause of blindness, yet it is preventable and treatable with routine screening [2]. According to the company, the barrier to screening has been fit rather than science, as screening tools built for specialists were not designed to fit the reality of primary care [2]. Optain provides an end-to-end solution that includes image capture, AI and teleophthalmology-based grading, and reporting, designed to fit within primary care settings [2]. The company operates in the hospitals and health care industry [3] and has 29 employees [3].

Alumni 2 went on to found or lead

• Eli BernsteinProduct Lead - US + Hardware→Chief Product Officer, Co-founder at Ascertain
• Mark MichalskiChairman of the Board→Chief Executive Officer at Ascertain

The full Optain mafia →

Something wrong or missing? Send a correction. Fixed within 24 hours.